Cargando…

High-titer anti-interferon-γ neutralizing autoantibodies linked to opportunistic infections in patients with adult-onset still's disease

OBJECTIVE: Neutralizing anti-interferon (IFN)-γ autoantibodies are linked to opportunistic infections (OIs). To explore the association between anti-IFN-γ autoantibodies and OIs in patients with adult-onset Still's disease (AOSD), we aimed to examine the ability of these autoantibodies to block...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Po-Ku, Liao, Tsai-Ling, Chang, Shih-Hsin, Yeo, Kai-Jieh, Chou, Chia-Hui, Chen, Der-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868624/ https://www.ncbi.nlm.nih.gov/pubmed/36698819 http://dx.doi.org/10.3389/fmed.2022.1097514

Ejemplares similares

The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity
por: Chen, Po-Ku, et al.
Publicado: (2023)

Increased Lipid Peroxidation May Be Linked to Ferritin Levels Elevation in Adult-Onset Still’s Disease
por: Chen, Po-Ku, et al.
Publicado: (2021)

Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections
por: Chi, Chih-Yu, et al.
Publicado: (2016)

Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains
por: Yasamut, Umpa, et al.
Publicado: (2019)

A Streamlined Diagnostic Process Improved the Outcomes of Patients with Adult-Onset Still’s Disease: A Single-Center Retrospective Observational Study
por: Chang, Shih-Hsin, et al.
Publicado: (2022)

Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
por: Kacar, Mark, et al.
Publicado: (2021)

Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult‐onset immunodeficiency patient with anti‐interferon‐γ autoantibodies
por: Chou, Yun‐Tse, et al.
Publicado: (2023)

Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies
por: Angkasekwinai, Nasikarn, et al.
Publicado: (2019)

Diagnostic and Therapeutic Challenges in Disseminated Mycobacterium colombiense Infection Caused by Interferon-γ Neutralizing Autoantibodies
por: Matono, Takashi, et al.
Publicado: (2023)

Talaromyces marneffei and Mycobacterium tuberculosis co-infection in a patient with high titer anti-interferon-γ autoantibodies: a case report
por: Qiu, Ye, et al.
Publicado: (2022)

Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019)

Asbestos exposure and autoantibody titers
por: Lee, Eunsoo, et al.
Publicado: (2020)

Disseminated Mycobacterium avium Infection Presenting with Bladder Lesions in a Patient with Interferon-γ-neutralizing Autoantibodies
por: Miyashita, Koichi, et al.
Publicado: (2018)

Disseminated Mycobacterium avium Infection Complicated with Chylous Ascites in a Patient with Neutralizing Autoantibodies to Interferon-γ
por: Yamaba, Yusuke, et al.
Publicado: (2020)

Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019)

Immune Alterations in Patients with Anti-Interferon-γ Autoantibodies
por: Chruewkamlow, Nuttapol, et al.
Publicado: (2016)

A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-γ
por: Nei, Takahito, et al.
Publicado: (2012)

Erratum: Asbestos exposure and autoantibody titers
por: Lee, Eunsoo, et al.
Publicado: (2021)

Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies
por: Hsieh, Hui-Shan, et al.
Publicado: (2022)

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection
por: Valour, Florent, et al.
Publicado: (2016)

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
por: Dunn, Nicky, et al.
Publicado: (2020)

Periocular Infection of Mycobacterium avium Complex in a Patient with Interferon-γ Autoantibodies: A Case Report
por: Lo, Tzu-Hui, et al.
Publicado: (2022)

Bacillus cereus isolated from a positive bone tissue culture in a patient with osteolysis and high-titer anti-interferon-γ autoantibodies: A case report
por: Qiu, Ye, et al.
Publicado: (2019)

Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies
por: Laisuan, Wannada, et al.
Publicado: (2020)

Refractory Urticaria with Raised Antistreptolysin O (ASO) Titer: An Intriguing Case of Adult-Onset Still’s Disease
por: Aldehaim, Abdulkarim Y., et al.
Publicado: (2020)

2709. Immune Response After Diphtheria and Tetanus Toxoid Booster in Patients with Adult-Onset Immunodeficiency with Anti-interferon-γ Autoantibody
por: Tovikkai, Dissaruj, et al.
Publicado: (2019)

An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics
por: Chen, Po-Ku, et al.
Publicado: (2021)

Elevated circulating levels of the interferon-γ–induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still’s disease
por: Han, Jae Ho, et al.
Publicado: (2017)

Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections
por: Chen, Zhao-Ming, et al.
Publicado: (2022)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19
por: Eto, Shohei, et al.
Publicado: (2022)

Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
por: Eto, Shohei, et al.
Publicado: (2022)

Antinuclear Autoantibodies and Lupus Nephritis in Transgenic Mice Expressing Interferon γ in the Epidermis
por: Seery, John P., et al.
Publicado: (1997)

Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease
por: Chen, Po-Ku, et al.
Publicado: (2020)

Epitope Mapping of Neutralizing Monoclonal Antibodies to Human Interferon-γ Using Human-Bovine Interferon-γ Chimeras
por: Zuber, Bartek, et al.
Publicado: (2016)

1360. Disseminated Mycobacterium abscessus Infections in Patients with Neutralizing Anti-interferon-gamma Autoantibodies Treated with Rifabutin-based Combination Regimens
por: Cheng, Aristine, et al.
Publicado: (2019)

Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection
por: Chen, Long-Fang, et al.
Publicado: (2021)

Cellular Immune Responses in HIV-Negative Immunodeficiency with Anti-Interferon-γ Antibodies and Opportunistic Intracellular Microorganisms
por: Wipasa, Jiraprapa, et al.
Publicado: (2014)

Disseminated Talaromyces marneffei and Mycobacterium abscessus in a Patient With Anti-Interferon-γ Autoantibodies
por: Pruetpongpun, Nattapol, et al.
Publicado: (2016)

Disseminated Mycobacterium avium complex infection in a woman with anti-interferon-γ autoantibodies
por: Dahl, Victor Naestholt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bn64igp49g31qgbua9chke3rjh